Certain morphological features of intravascular lesions appear to be predictors for the “no-reflow” phenomenon–failure to restore normal myocardial blood flow–following balloon angioplasty or stenting. In
NEW YORK (Reuters Health) May 28 – Findings from a recent animal study suggest that ramipril could be a useful treatment for the peripheral vascular
New evidence that increasing average intake of fruit and vegetables to five servings a day reduces blood pressure and cuts the risk of cardiovascular disease
05/27/2002 By Elda Hauschildt Use of naproxen, a non-steroidal anti-inflammatory drug (NSAID), has been associated with reduced risk of heart attack. Naproxen was associated with
Early revascularisation substantially improves one-year survival after a first acute myocardial infarction (AMI). Investigators studying a prospective cohort of AMI patients admitted to 61 Swedish
Lancet 05/16/2002 By Harvey McConnell The presence of anemia appears to increase mortality risk in patients undergoing cardiac artery bypass surgery in the days after
Chest 05/21/2002 By Robert Short Doctors may drastically overestimate the probability of severe complication for acute congestive heart failure, possibly resulting in over-use of scarce
YORK (Reuters Health) May 23 – Guidant Corp. said on Thursday that preliminary results of a single-blinded clinical study comparing the company’s Achieve paclitaxel-coated stent
Lancet 05/24/2002 By Harvey McConnell Early revascularisation substantially improves one-year survival after a first acute myocardial infarction (AMI). Investigators studying a prospective cohort of AMI
ANN ARBOR, MI — May 21, 2002 — Emergency room physicians can deliver clot-busting drugs to appropriate stroke patients as quickly and safely as dedicated
05/22/2002 By David Loshak The enhanced potential to release endothelin-1 in patients with unstable angina might account, at least in part, for greater vasoreactivity of
NEW YORK (Reuters Health) May 22 – Analysis of data from the Survival and Ventricular Enlargement (SAVE) trial shows that right ventricular function is an
CHICAGO (Reuters) May 22 – Healthcare products maker Johnson & Johnson reported new evidence on Wednesday that its sirolimus-coated stent, used to treat stenotic coronary
05/23/2002 By James Adams Losartan normalizes the response of the left main coronary artery to the cold pressor test in patients with essential hypertension independently
Special to DG News NEW YORK, NY — May 20, 2002 — Cardiac electrical instability — specifically QT and QTc dispersions — appears to be
Special to DG News NEW YORK, NY — May 19, 2002 — The investigational selective aldosterone blocker, eplerenone, appears to be more effective in reducing
Special to DG News NEW YORK, NY — May 19, 2002 — Perindopril erbumine appears to be effective as an antihypertensive agent and well tolerated
Special to DG News NEW YORK, NY — May 19, 2002 — Nighttime dosing with diltiazem hydrochloride extended release (G99) provides effective blood pressure control
Special to DG News NEW YORK, NY — May 19, 2002 — Researchers report that controlled onset extended release verapamil failed to meet its goal
Special to DG News NEW YORK, NY — May 19, 2002 — More than 90 percent of patients in the VALUE (Valsartan Antihypertensive Long-term Use